| Literature DB >> 33912311 |
Taamallah Karima1, Ben Zaied Nesrine1, Lahdhili Hatem1, Ben Omrane Skander2, Denguir Raouf2, Chenik Selim1.
Abstract
To the best of our knowledge there are no publications about Tunisian experience in constrictive pericarditis (CP); the aim of this study was therefore to review our twenty-one years' experience in terms of clinical and surgical outcomes and risk factors of death after pericardiectomy. An analytic bicentric and retrospective study carried out on 25 patients (20 male) with CP underwent pericardiectomy, collected over a 21-years period. The mean age was 40.46±16.74 years [7.5-72]. The commonest comorbid factor was tabagism (52%). The most common etiology was tuberculosis (n = 11, 44%). Dyspnea was the most common functional symptom (n = 21, 84%). Pericardiectomy was performed in all our patients within 2.9±3.19 months after confirmation of diagnosis. It was subtotal in 96% of cases. The commonest postoperative complications are pleural effusion (20%). Dyspnea was regressed within 1.8 months in 80% of cases and clinical signs of right heart failure within a mean duration of 1.62 months in 53% of cases. Perioperative mortality was 12% (3 deaths), late mortality was 4% (1 patient). Cardiopulmonary bypass, New York Heart Association (NYHA) over class II and right ventricular dysfunction are the prognostic factors of mortality (p = 0.001, 0.046, 0.019). Tuberculosis as etiology of CP had no impact on mortality. CP is a rare disease, with non-specific clinical signs. Pericardiectomy is effective with a significant improvement of the functional status of patients and favorable outcome at short and long term nevertheless hospital mortality is not negligible and depends on many factors. Copyright: Taamallah Karima et al.Entities:
Keywords: Constrictive pericarditis; echocardiography; pericardiotomy; prognosis; tuberculosis
Mesh:
Year: 2021 PMID: 33912311 PMCID: PMC8052615 DOI: 10.11604/pamj.2021.38.141.22884
Source DB: PubMed Journal: Pan Afr Med J
patient´s comorbidities
| Comorbidity | Number (n) | Percentage (%) |
|---|---|---|
| Tabagism | 13 | 52 |
| Ethylism | 5 | 20 |
| Diabetes | 1 | 4 |
| Systemic arterial hypertension | 0 | |
| Coronary artery disease | 0 | |
| Valvulopathy | 3 | 12 |
| Stroke | 1 | 4 |
| Chronic obstructive pulmonary disease (COPD) | 1 | 4 |
clinical signs
| Number of the case (n) | Percentage (%) | |
|---|---|---|
| Dyspnea | 21 | 84 |
| Chest pain | 6 | 24 |
| Liver pain on exertion | 5 | 20 |
| Digestive signs | 4 | 16 |
| Asthenia | 2 | 4 |
| Palpitations | 1 | 8 |
| Weight loss | 1 | 4 |
| No symptoms | 1 | 4 |
| Pericardial knock | 2 | 8 |
| Muffled heart sounds | 9 | 36 |
| Jugular venous distension | 18 | 72 |
| Hepatojugular reflux | 14 | 56 |
| Hepatomegaly | 19 | 76 |
| Peripheral edema | 16 | 64 |
| Splenomegaly | 2 | 8 |
| Ascites | 10 | 40 |
| Pleural effusion | 4 | 16 |
laboratory tests
| Anomaly | Number of the case (n) | Percentage (%) |
|---|---|---|
| Anemia | 5 | 20 |
| Thrombocytopenia | 8 | 32 |
| Leukopenia | 2 | 8 |
| Hepatic cytolisis | 4 | 16 |
| Cholestasis | 9 | 36 |
| Increased Acid Uric Level | 1 | 4 |
| Hyponatremia | 4 | 16 |
| Decreased Prothrombin Time | 12 | 48 |
echocardiographic signs
| Echocardiographic signs | Number of patients | Percentage (%) |
|---|---|---|
| Biatrial dilation | 24 | 96 |
| Septal notch | 20 | 80 |
| Pericardial thickening | 20 | 80 |
| Inferior vena cava dilation | 17 | 68 |
| Inferior vena cava plethora | 12 | 48 |
| Pericardial calcifications | 9 | 36 |
| Pericardial effusion | 6 | 24 |
| Left ventricular dysfonction | 3 | 12 |
| Right ventricular dysfonction | 10 | 40 |
| Prosthetic valve and native valvulopathy | 4 | 16 |
| E/A>0.8 | 25 | 100 |
| Respiration-related variation in mitral inflow velocities | 15 | 60 |
| Respiration-related variation in tricuspid inflow velocities | 7 | 28 |
| E/A>2(restrictive mitral flow) | 4 | 16 |
| Reflux in hepatic vein | 2 | 8 |
| Pulmonary regurgitation flow: Dip-plateau | 6 | 24 |
E: Protodiastolic wave of mitral flow, A= End-diastolic wave in mitral inflow
cardiac catheterization
| Séries | Average | Extremes |
|---|---|---|
| Mean right atrial pressure (mmHg) | 22.38±5.67 | (21-31) |
| Mean right ventricle end-diastolic pressure (mmHg) | 20.07±3.8 | (15-30) |
| Mean diastolic pulmonary arterial pressure (mmHg) | 25±8 | (16-45) |
| Mean wedged pulmonary artery pressure (mmHg) | 22.32±5 | (15-31) |
| Mean left ventricle end diastolic pressure(mmHg) | 26.5±9 | (20-44) |
post-operative complications
| Number of patients | Pourcentage (%) | |
|---|---|---|
| Deaths | 3 | 12 |
| Pleural effusion | 5 | 20 |
| Bleeding | 4 | 16 |
| Low cadiac output | 3 | 12 |
| Sepsis | 2 | 8 |
| Decompensation COPD | 1 | 4 |
| Bronchopulmonary infection | 1 | 4 |
| Atrial fibrillation | 1 | 4 |
| Reoperation | 2 | 8 |
risk factors of in-hospital and global mortality
| Risk factors | In-hospital mortality | Late mortality | Global mortality |
|---|---|---|---|
| Increased cardiothoracic ratio | p = 0.430 | p = 0.778 | p = 0.81 |
| Age >44 ans | p = 0.260 | p = 0.667 | p = 0.16 |
| Male gender | p = 0.633 | p = 0.889 | p = 0.21 |
| CP post cardiotomy | p = 0.230 | p = 0.889 | p = 0.54 |
| CP post-tuberculosis | p = 0.697 | p = 0.556 | p = 0.42 |
| COPD | p = 0.920 | p = 0.889 | p = 0.61 |
| NYHA III-IV | p = 0.070 | p = 0.045 | |
| Hepatomegaly | p = 0.570 | p = 0.778 | p = 0.81 |
| Cirrhosis | p = 0.843 | p = 0.111 | p = 0.27 |
| Cholestasis | p = 0.59 | p = 0.500 | p = 0.37 |
| Hyponatremia | p = 0.338 | p = 0.857 | p = 0.90 |
| LV dysfunction | p = 0.230 | p = 0.18 | p = 0.54 |
| p = 0.055 | p = 0.068 | ||
| Pericardial calcifications (chest radiography, TTE, CT, MRI) | p = 0.27 | p = 0.33 | p = 0.06 |
| p =0.66 | |||
| Catecholamine use | p = 0.625 | p = 0.333 | p = 0.87 |
| Blood transfusion | p = 0.700 | p = 0.222 | p = 0.78 |
| Platelet transfusion | p = 0.843 | p = 0.111 | p = 0.27 |